Physician profile
Thomas V Harmon
NPI 1245268507
$9,810.86
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.56 · 2020: $147 · 2021: $9,163 · 2022: $334 · 2024: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,239.10 | 2020-2022 | |
| Ethicon US, LLC | $111.37 | 2021 | |
| Medtronic, INC. | $105.38 | 2024 | Ligasure |
| Tela Bio, INC. | $76.86 | 2022 | |
| Davol INC. | $66.19 | 2020-2022 | |
| Boston Scientific Corporation | $54.86 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.75 | 2022 | |
| Coloplast Corp | $27.83 | 2019 | |
| Organogenesis INC. | $19.71 | 2022 | |
| Covidien Lp | $19.67 | 2019 | |
| Acacia Pharma INC | $14.95 | 2021 | |
| Amgen INC. | $14.06 | 2019 | |
| Integra Lifesciences Corporation | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.